Synovial Sarcoma, X Breakpoint 7 (SSX7) Peptide
Our Local Distributor
北京 101111
Quick Overview for Synovial Sarcoma, X Breakpoint 7 (SSX7) Peptide (ABIN939345)
抗原
宿主
资源
应用范围
-
-
蛋白类型
- Synthetic
-
序列
- IFPKIMPKKP AEEGNDSKGV PEASGSQNDG KHLCPPGKPS TSEKINKTSG
-
产品特性
-
A synthetic peptide for use as a blocking control in assays to test for specificity of SSX7 antibody,
Alternative Names: SSX7 control peptide, SSX7 antibody Blocking Peptide, Anti-SSX7 Blocking Peptide, synovial sarcoma, X breakpoint 7 Blocking Peptide, SSX7, SSX-7, SSX 7, SSX-7 Blocking Peptide, SSX 7 Blocking Peptide
-
-
-
-
应用备注
- Optimal conditions should be determined by the investigator
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
溶解方式
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
缓冲液
- PBS
-
注意事项
- Avoid repeated freeze/thaw cycles.
-
储存条件
- -20 °C
-
储存方法
- Store at -20 °C long term.
-
-
- SSX7 (Synovial Sarcoma, X Breakpoint 7 (SSX7))
-
背景
- SSX7 belongs to the family of highly homologous synovial sarcoma X (SSX) breakpoint proteins. These proteins may function as transcriptional repressors. They are also capable of eliciting spontaneously humoral and cellular immune responses in cancer patients, and are potentially useful targets in cancer vaccine-based immunotherapy. SSX1, SSX2 and SSX4 genes have been involved in the t(X,18) translocation characteristically found in all synovial sarcomas.
-
分子量
- 21 kDa
抗原
-